#Semaglutide I #Patent_cliff I #Market I #generics I #global_scale I #India I Systematix Group Read more: To view or add a comment, sign in Analysis: The loss of #Semaglutide patents is a major strategic turning point for #IndianPharma, unlocking an estimated 5,000 crore (~$600M) #GenericOpportunity across #India and regulated #EmergingMarkets like #Canada and #Brazil as exclusivity ends
WISEMAN: The biggest thing I say is planning - thinking about what your life is like, thinking about what your schedule is like, and then where do, you know, foods to take a little bit more time, preparation, where does that fit in
M., Yasar, S., van Heemst, D
This property helps in streamlining how much insulin your system makes and also pace at which your digestive system works to empty foods you consume
Its probably no secret that Suzanne Somers is a self-proclaimed takes-chemicals-very-seriously kind of person